Related Experiment Video
Updated: May 19, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Computerised assistance for warfarin dosage--effects on treatment quality
Ivar Dimberg1, Bartosz Grzymala-Lubanski, Anette Hägerfelth
1Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, SE-118 83 Stockholm, Sweden.
European Journal of Internal Medicine
|August 25, 2012
Summary
The AuriculA web-based system improved warfarin dosing quality, significantly increasing the time in therapeutic range (TTR) in one center and maintaining it in another. This computerised system enhances anticoagulation management for patients on warfarin.
Area of Science:
- Cardiology
- Pharmacology
- Health Informatics
Background:
- Effective warfarin management, indicated by a high time in therapeutic range (TTR), is crucial for minimizing bleeding and thromboembolic events.
- Many healthcare facilities manually manage warfarin dosing, lacking insight into their TTR and overall treatment quality.
- AuriculA, a national web-based anticoagulation dosing system in Sweden, was developed to address this gap.
Purpose of the Study:
- To evaluate the impact of the AuriculA web-based dosing system on warfarin treatment quality compared to manual dosing.
- To determine if AuriculA improves or maintains a high time in therapeutic range (TTR) in patients with atrial fibrillation.
Main Methods:
- A retrospective cohort study was conducted using medical records from two centers that previously used manual warfarin dosing.
- Data on TTR were manually extracted for periods of manual dosing and compared with data from the computerized AuriculA regimen.
- Patient cohort included individuals with atrial fibrillation undergoing warfarin treatment.
Main Results:
- In the first center, mean TTR significantly increased from 64.3% to 71.3% (p=0.03) after AuriculA implementation.
- The second center maintained a high TTR (73.6% to 74.0%) following the introduction of AuriculA.
- The frequency of International Normalized Ratio (INR) tests increased by 20% and 21% in the respective centers after adopting AuriculA.
Conclusions:
- Computerised dosing assistance via the AuriculA system effectively improves or sustains high warfarin treatment quality, as measured by TTR.
- AuriculA demonstrates a positive impact on anticoagulation management, contributing to better patient outcomes.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:25Dosage Regimen: Multiple Oral Dosage
Understanding how a drug's concentration fluctuates within the body over time is crucial in pharmacokinetics, particularly with multiple oral doses. A graphical representation of multiple oral dosages provides insight into these dynamics. Typical accumulation curves of a drug's concentration in the body reveal a sawtooth pattern, indicating periodic peaks and troughs correlating with each dose administration and the drug's subsequent elimination.The plasma concentration at any time during an...